Tokyo, May 14, 2006 (JCN) - Mitsubishi Pharma announced on May 11 that it will set up a pharmaceutical development subsidiary in Beijing in October. To be capitalized at $1 million, Mitsubishi Pharma R&D (Beijing) (provisional name) will initially employ about 10 people.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.